Clinical case: Effectiveness of combined therapy Orlistat and Irbesartan at the Metabolic syndrome patient with Arterial hypertension
About the Authors
К. ИвановRussian Federation
В. Мычка
Russian Federation
М. Кириллова
Russian Federation
И. Чазова
Russian Federation
K. P. Ivanov
Russian Federation
V. B. Mychka
Russian Federation
M. J. Kirillov
Russian Federation
I. E. Chazova
Russian Federation
References
1. Чазова И.Е., Мычка В.Б. Метаболический синдром. М., 2008.
2. Reaven G, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympatoadrenal system. N Engl J Med 1996; 334: 374-81
3. Filer JS. Leptin resistance and obesity. Presented at the 60 th Scientific Sessions of the american diabetes association. June 13, 2000. San-Antonio, Texas.
4. Диагностика и лечение метаболического синдрома. Российские рекомендации. Кардиоваск. тер. и проф. Прил. 2. 2007; 6(6).
5. Диагностика и лечение артериальной гипертензии. Российские рекомендации. Кардиоваск. тер. и проф. Прил. 2. 2008; 7(6).
Review
For citations:
, , , , Ivanov K.P., Mychka V.B., Kirillov M.J., Chazova I.E. Clinical case: Effectiveness of combined therapy Orlistat and Irbesartan at the Metabolic syndrome patient with Arterial hypertension. Systemic Hypertension. 2009;(1):64-66.
Email this article 